The revision to the parent grant, 5 R01 DK081371-02: """"""""Identifying Disparities in Type 2 Diabetes Among Asian Americans: The Pan Asian Cohort Study,"""""""" is in response to NOT-OD-09-058: """"""""NIH Announces the Availability of Recovery Act Funds for Competitive Revision Applications."""""""" The parent grant is funded from January 15, 2009 - December 31, 2013 in response to Program Announcement PA-07-388: """"""""Identifying and Reducing Diabetes and Obesity Related Health Disparities within Healthcare Systems (R01)."""""""" This five-year study addresses the lack of knowledge regarding type 2 diabetes and obesity in Asian Americans, both as an aggregate group and as distinct subgroups. Relatively little is known about how Asian subgroups differ in type 2 diabetes riskfactors and complications when compared to the Non-Hispanic White population, for which numerous study findings have informed both practice of care and public health efforts in the United States. The parent grant utilizes a mixed historical and prospective longitudinal cohort to address these research questions of significant public health import, linking existing clinical databases to construct a large (140,000 Asian adults) cohort of a multiethnic sample of contemporary Asians in California. The revision, a two-year study, aims to additionally compare the effectiveness of oral drugs for treatment of type 2 diabetes among Asian subgroups in the same electronically linked cohort. It is well-known that type 2 diabetes manifests differently in race/ethnic groups, and that race/ethnic groups respond differently to the same pharmacotherapy. Treatment options for type 2 diabetes are numerous, and previous studies have demonstrated differences in metabolic responses to certain oral drugs according to race/ethnicity. This creates a need for more race/ethnic specific data comparing the effects of medication use to be able to improve diabetes care in Asian Americans in the United States. The wealth of real-life data captured within the clinical cohort will be utilized to compare the effectiveness of oral drugs to treat type 2 diabetes among Asian subgroups and to study existing preferences for certain drugs among patients and physicians. Predictors of initial choice of oral drug (in physicians and patients), intermediate and long-term effectiveness of existing oral drugs on type 2 diabetes and its complications, and the cost-effectiveness of these therapies will be investigated under this competitive revision. This revision will contribute valuable knowledge for physicians, patients, and public health advocates on the clinical and cost effectiveness of various oral type 2diabetes therapies in Asian Americans.

Public Health Relevance

Asian Americans (Asian Indian, Chinese, Filipino, Japanese, Korean, and Vietnamese) are disproportionately affected by type 2 diabetes. There is no data on comparative effectiveness of oral drugs to treat type 2 diabetes in Asian American subgroups. Our study will address this gap in knowledge.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-PSE-B (95))
Program Officer
Staten, Myrlene A
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Palo Alto Medical Foundation Research Institute
Palo Alto
United States
Zip Code
Osmundson, Sarah S; Zhao, Beinan S; Kunz, Liza et al. (2016) First Trimester Hemoglobin A1c Prediction of Gestational Diabetes. Am J Perinatol 33:977-82
Chung, Sukyung; Johns, Nicole; Zhao, Beinan et al. (2016) Clocks Moving at Different Speeds: Cultural Variation in the Satisfaction With Wait Time for Outpatient Care. Med Care 54:269-76
Zhao, Beinan; Jose, Powell O; Pu, Jia et al. (2015) Racial/ethnic differences in hypertension prevalence, treatment, and control for outpatients in northern California 2010-2012. Am J Hypertens 28:631-9
Chung, Sukyung; Zhao, Beinan; Lauderdale, Diane et al. (2015) Initiation of treatment for incident diabetes: evidence from the electronic health records in an ambulatory care setting. Prim Care Diabetes 9:23-30
Chung, Sukyung; Lesser, Lenard I; Lauderdale, Diane S et al. (2015) Medicare annual preventive care visits: use increased among fee-for-service patients, but many do not participate. Health Aff (Millwood) 34:11-20
Azar, Kristen M J; Chung, Sukyung; Wang, Elsie J et al. (2015) Impact of Education on Weight in Newly Diagnosed Type 2 Diabetes: Every Little Bit Helps. PLoS One 10:e0129348
Pu, Jia; Romanelli, Robert; Zhao, Beinan et al. (2015) Dyslipidemia in special ethnic populations. Cardiol Clin 33:325-33
Pu, Jia; Zhao, Beinan; Wang, Elsie J et al. (2015) Racial/Ethnic Differences in Gestational Diabetes Prevalence and Contribution of Common Risk Factors. Paediatr Perinat Epidemiol 29:436-43
Romanelli, Robert J; Chung, Sukyung; Pu, Jia et al. (2015) Comparative effectiveness of early versus delayed metformin in the treatment of type 2 diabetes. Diabetes Res Clin Pract 108:170-8
Chung, Sukyung; Azar, Kristen M J; Baek, Marshall et al. (2014) Reconsidering the age thresholds for type II diabetes screening in the U.S. Am J Prev Med 47:375-81

Showing the most recent 10 out of 31 publications